Eyenovia(EYEN)

Search documents
Eyenovia(EYEN) - 2019 Q2 - Earnings Call Transcript
2019-08-13 02:09
Eyenovia, Inc. (NASDAQ:EYEN) Q2 2019 Results Earnings Conference Call August 12, 2019 4:30 PM ET Company Participants Tram Bui - The Ruth Group Sean Ianchulev - CEO and Chief Medical Officer John Gandolfo - CFO Conference Call Participants Matt Kaplan - Ladenburg Thalmann Yi Chen - H.C. Wainwright Operator Good day, ladies and gentlemen. Thank you for standing by. And welcome to Eyenovia, Inc. Second Quarter 2019 Earnings Conference Call. [Operator Instructions] As a reminder, this conference may be recorde ...
Eyenovia(EYEN) - 2019 Q1 - Quarterly Report
2019-05-14 20:20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ______________________ COMMISSION FILE NUMBER: 001-38365 EYENOVIA, INC. (Exact name of Registrant as Specified in Its Charter) DELAWARE 47-1178401 (S ...
Eyenovia(EYEN) - 2019 Q1 - Earnings Call Transcript
2019-05-14 15:42
Eyenovia, Inc. (NASDAQ:EYEN) Q1 2019 Earnings Conference Call May 14, 2019 8:30 AM ET Company Participants Tram Bui - The Ruth Group Sean Ianchulev - CEO, President, Chief Medical Officer & Director John Gandolfo - CFO & Secretary Conference Call Participants Esther Rajavelu - Oppenheimer Maria Barbera - Ladenburg Thalmann & Co. Yi Chen - H.C. Wainwright & Co. Jonathan Aschoff - National Securities Corporation Operator Good morning, ladies and gentlemen, and welcome to the Eyenovia First Quarter 2019 Earnin ...
Eyenovia(EYEN) - 2018 Q4 - Annual Report
2019-03-27 21:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ______________________ COMMISSION FILE NUMBER: 001-38365 EYENOVIA, INC. | --- | --- | |--------------------------------------------------|---------------- ...
Eyenovia(EYEN) - 2018 Q4 - Earnings Call Transcript
2019-03-27 18:05
Eyenovia, Inc. (NASDAQ:EYEN) Q4 2018 Earnings Conference Call March 27, 2019 8:30 AM ET Company Participants Tram Bui - The Ruth Group Sean Ianchulev - CEO & Chief Medical Officer John Gandolfo - CFO Conference Call Participants Matt Kaplan - Ladenburg Thalmann Scott Henry - ROTH Capital Jonathan Aschoff - National Securities Yi Chen - H.C. Wainwright Operator Good day ladies and gentlemen and welcome to the Eyenovia Fourth Quarter and Full Year 2018 Earnings Conference Call. At this time, all participants ...